SYNCOM ACQUIRES PAIN RELIEF PRODUCT LINE FROM ACTIUM PHARMACEUTICALS, INC
Syncom Acquires pain relief product line from Actium Pharmaceuticals, Inc.
October 20, 2007 - FAIRFIELD, N.J.: Syncom Pharmaceuticals, a leading provider of contract sales services for drug developers, device manufacturers and marketers - announces the acquisition of the exclusive sales and distribution rights within the US market to FORTEX Rubbing Oil® from Actium Pharmaceuticals, Inc.
FORTEX is an innovative topical analgesic that provides rapid and long-lasting relief of pain associated with musculoskeletal conditions, such as arthritis and muscle soreness. It provides rapid subcutaneous absorption under the site of application via its unique drug delivery system. Fortex reaches deep into the tissue to activate its analgesic and anti-inflammatory action without significant systemic absorption. Therefore, Fortex provides an effective and safe alternative (or adjunct) to pills and other medications taken by mouth for many musculoskeletal conditions.
Syncom Acquires pain relief product line from Actium Pharmaceuticals, Inc.
October 20, 2007 - FAIRFIELD, N.J.: Syncom Pharmaceuticals, a leading provider of contract sales services for drug developers, device manufacturers and marketers - announces the acquisition of the exclusive sales and distribution rights within the US market to FORTEX Rubbing Oil® from Actium Pharmaceuticals, Inc.
FORTEX is an innovative topical analgesic that provides rapid and long-lasting relief of pain associated with musculoskeletal conditions, such as arthritis and muscle soreness. It provides rapid subcutaneous absorption under the site of application via its unique drug delivery system. Fortex reaches deep into the tissue to activate its analgesic and anti-inflammatory action without significant systemic absorption. Therefore, Fortex provides an effective and safe alternative (or adjunct) to pills and other medications taken by mouth for many musculoskeletal conditions.
“We are pleased to transfer Fortex US rights to Syncom. Their proposed marketing model, core competencies and people all combine for a great fit with FORTEX,” said Michel Lockhart, President at Actium Pharmaceuticals. “We have the utmost confidence that our partnership with Syncom will result in clear benefits for health professionals, and most of all for patients. Syncom has the resources to reach more patients through a wide range of health professionals who treat arthritis and muscular soreness. These contacts mean more patient exposures and a greater opportunity for them to experience the effective and safe benefits of FORTEX.”
Syncom’s distribution strategy for FORTEX will be directed to consumers through recommendations from healthcare professionals. The company will continue to leverage its contract sales-force while providing targeted outsourcing services to drug and device developers.
Jim DeCoursin, Chairman and CEO of Syncom said, “The acquisition of FORTEX bolsters Syncom’s strategic business model. The addition of a high quality product like FORTEX to our in-house product portfolio allows us to continue to expand our contract sales services while benefiting from lucrative, internally-generated revenue streams.”
For further inquiries about Fortex Rubbing Oil, visit http://fortex.syncomsales.net
About Syncom Pharmaceuticals:
Syncom Pharmaceuticals is a leading contract-sales service provider that delivers tailor-made business solutions to pharmaceutical and medical-device developers. Leveraging a highly-experienced, carefully-selected team of sales representatives dispersed throughout the United States, Syncom offers flexible, customer-driven outsourcing solutions that compliment and enhance existing in-house sales initiatives. With more than twenty years of contract-sales experience, Syncom has successfully delivered business services to a vast number of Pharmaceutical organizations – from emerging drug developers to Fortune100 Companies. Syncom’s suite of scalable outsourcing solutions enables clients to increase and intensify sales coverage throughout the US without raising fixed capital costs. Syncom solutions allow drug developers to aggressively launch new therapeutic products, expand market reach to new geographic locations and maximize existing market share - without fear of over-employment or underselling. www.syncom.net
Syncom Pharmaceuticals, Inc.
6 Gloria Lane
Fairfield, NJ 07004-3306
Telephone: 1(973) 787-2405
